We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Nanoparticles Demonstrate Use as Injectable Marker

By HospiMedica International staff writers
Posted on 01 Aug 2017
Researchers have found a new tissue adhesive that can be detected by clinical imaging modalities, and is also extremely biocompatible for minimally invasive procedures.

The injectable biocompatible radiopaque Tantalum oxide/Silica core/shell Nanoparticles (TSN) were not only very adhesive, but also demonstrated high-contrast for real-time imaging. More...
Adhesives are becoming a convenient alternative to staples and sutures for reconnecting injured tissues and closing wounds following trauma or surgery, especially in minimally invasive procedures.

The results were published online in the July 19, 2017, issue of the journal Nature Communications by the researchers from the Seoul National University (Seoul, South Korea) and other academic and medical institutions in South Korea. The TSN particles cause significantly less inflammation, and cellular toxicity than CyanoAcrylate and Lipiodol (CA-Lp), imageable tissue adhesives.

TSNs could be used for image-guided procedures such as needle biopsy, catheter-directed embolotherapy, percutaneous angioplasty, vertebroplasty and Radio Frequency (RF) / microwave ablation. These minimally invasive procedures are increasingly used to replacing conventional surgery to control internal bleeding, to perform organ biopsies, and for vessel occlusion for example.

The researchers were able to demonstrate that the TSN glue was clearly visualized by X-Ray fluoroscopy, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), ultrasound, and other clinical modalities. Tantalum oxide is inert, takes time to biodegrade in the body, and is normally only required in very small quantities in image-guided procedures, and remain in the target area without any extreme severe adverse reactions.

Related Links:
Seoul National University


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Spirometry & Oximetry Software
MIR Spiro
X-Ray System
Leonardo DR mini III
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.